METHOD AND APPARATUS FOR PURIFYING AIR FROM BIOLOGICAL AGENTS AND VOLATILE ORGANIC COMPOUNDS
20230089967 · 2023-03-23
Inventors
- Uri Stoin (Jerusalem, IL)
- Yoel SASSON (Tel Aviv, IL)
- Marat MAAYAN (Ramat-Gan, IL)
- Evgeny GAMERMAN (Petah-Tikva, IL)
- Avraham Zakay (Tel Aviv, IL)
Cpc classification
F24F8/108
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F24F2110/66
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F24F2120/10
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F24F8/133
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F24F2110/70
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
B01D2257/708
PERFORMING OPERATIONS; TRANSPORTING
International classification
F24F8/133
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
Abstract
A method for improving indoor air quality in a room, comprising drawing air from the room and guiding the air into a gas/liquid contactor charged with aqueous alkali hydroxide/H.sub.2O.sub.2 solution, passing the air through a perforated membrane installed in the gas/liquid contactor below the surface level of the aqueous alkali hydroxide/H.sub.2O.sub.2 solution, such that bubbles produced travel through said solution, and getting treated air with improved quality from said gas/liquid contactor, said treated air is characterized by having: reduced carbon dioxide levels; and/or reduced VOC levels; and/or reduced microbiological load. An air purifier to carry out the method is also provided.
Claims
1) A method for improving indoor air quality in a room, comprising drawing air from the room and guiding the air into a gas/liquid contactor charged with aqueous alkali hydroxide/H.sub.2O.sub.2 solution, passing the air through a perforated membrane installed in the gas/liquid contactor below the surface level of the aqueous alkali hydroxide/H.sub.2O.sub.2 solution, such that bubbles produced travel through said solution, and getting treated air with improved quality from said gas/liquid contactor, said treated air is characterized by having: reduced carbon dioxide levels; and/or reduced VOC levels; and/or reduced microbiological load.
2) The method according to claim 1, wherein the air is passed through the membrane via perforations whose diameter increases across the membrane thickness.
3) The method according to claim 2, wherein each of the perforations is a passage consisting of a cylindrical section joining an inverted frustoconical section facing the solution, or a passage shaped as a frustrum of a cone with its large base facing the solution.
4) The method according to claim 1, wherein the aqueous alkali hydroxide/H.sub.2O.sub.2 solution is charged to the gas/liquid contactor either by feeding alkali hydroxide solution prepared beforehand or by dissolving solid alkali hydroxide in water supplied separately to the gas/liquid contactor, with continuous or periodic addition of hydrogen peroxide solution to the alkali hydroxide solution.
5) The method according to claim 4, comprising periodic dissolution of solid alkali hydroxide in a tablet form to water supplied separately to the gas/liquid contactor.
6) The method according to claim 1, wherein the concentration of the alkali hydroxide solution is from 5 to 48%-50% by weight, the concentration of the hydrogen peroxide solution added is from 3 to 35% by weight, with volumetric ratio between the solutions in the range of 2:1 to 10:1 in favour of the alkali hydroxide solution, wherein the ratio is adjusted based on the CO.sub.2 level and/or microbial load.
7) The method according to claim 1, comprising: drawing indoor air and passing same, at a first flow rate, across a filter to capture airborne particles and produce a main filtered air stream; diverting a portion of the main filtered air stream to generate a secondary filtered air stream flowing at a second flow rate; forcing said secondary filtered air stream into a gas/liquid contactor charged with the aqueous alkali hydroxide/H.sub.2O.sub.2 solution, where the filtered air, in the form of bubbles, is contacted with said solution; withdrawing filtered and decontaminated air stream from said gas/liquid contactor; and joining said filtered and decontaminated air stream with the main filtered air stream.
8) The method according to claim 1, wherein CO.sub.2 level in indoor environment is reduced from 1000-10,000 ppm down to than 400-700 ppm.
9) The method according to claim 1, wherein VOC level in indoor environment is reduced.
10) The method according to claim 9, wherein the VOC is formaldehyde.
11) The method according to claim 1, wherein bacterial load and/or viral load in indoor environment is reduced by at least 2 log reduction.
12) An air purifier for eliminating chemical and biological pollutants from a room, comprising: an inlet air channel; one or more air sucking components configured to direct air from the room into said inlet channel, and to direct the air via said air channel into a perforated membrane mounted in a chemical and biological pollutants-elimination reactor; and an outlet air channel configured to receive treated air from the reactor; wherein the reactor comprises: a reservoir configured to contain a purifying aqueous alkali hydroxide/H.sub.2O.sub.2 solution; wherein during the purifier's operation, said perforated membrane is positioned below a surface level of the solution such that air passing through the perforated membrane is converted into bubbles that travel through the solution and towards said outlet channel; and wherein the air purifier further comprises a removable storage unit positioned above the reactor, said removable storage unit is configured to contain and supply alkali hydroxide, hydrogen peroxide, and optionally water to said reactor.
13) The air purifier according to claim 12, wherein said inlet air channel conveys air in a downwards direction, the inlet air channel passes through an opening in said perforated membrane towards an air compartment located below the perforated membrane.
14) The air purifier according to claim 12, wherein a bottom outlet of said inlet air channel is sealed against a top surface of the perforated membrane, thereby to allow passage of air from the inlet air channel only through the perforations of the membrane towards a section of the reservoir below the membrane, and wherein the diameter of said membrane is smaller than the diameter of said reservoir of alkali hydroxide/H.sub.2O.sub.2 solution.
15) The air purifier according to claim 12, wherein each perforation at the membrane has a diameter in the range of between 40 μm and 1200 μm.
16) The air purifier according to claim 12, characterized in that the perforated membrane has perforations with top and bottom openings, respectively, at top and bottom surfaces of the perforated membrane, the diameter of said top opening is larger than a diameter of said bottom opening.
17) The air purifier according to claim 16, wherein each of the perforations is divided into two sections in cross-section, a lower section having a cylindrical shape, and an upper section having a frustoconical shape.
18) The air purifier according to claim 12, wherein a bottom outlet of said inlet air channel is configured to lead contaminated air to a perforated membrane, said perforated membrane having a spiral tubing configuration and positioned at a lower portion of said purifying solution's reservoir.
19) The air purifier according to claim 18, wherein each said perforations is positioned at a lower portion of the tubing in cross section, thereby directing air outlet through the perforation downwards.
20) The air purifier according to claim 19, wherein each of said perforations is positioned at least 30° lower than the tubing horizontal diameter in cross-section.
21) The air purifier according to claim 18, wherein each of said perforations has a diameter in the range of between 40 μm and 1200 μm.
22) The air purifier according to claim 18, wherein a distance between each two perforations is in the range of 2-50 of the perforation's diameter.
23) The air purifier according to claim 12, wherein said storage unit comprises an alkali hydroxide container, a H.sub.2O.sub.2 container, and optionally a water container.
24) The air purifier according to claim 23, having an essentially cylindrical shape, wherein said alkali hydroxide container, said H.sub.2O.sub.2 container, and said water container are arranged concentrically within the storage unit.
25) The air purifier according to claim 23, wherein the alkali hydroxide container is configured to contain alkali hydroxide tablets in a releasable arrangement.
26) The air purifier according to claim 25, wherein said alkali hydroxide container comprises a plurality of columns, each column is configured to store alkali hydroxide tablets.
27) The air purifier according to claim 26, wherein said hydroxide container is configured to angularly revolve, thereby to position a single column above an opening to a passage leading to said solution reservoir, thereby to allow a periodical feeding of the solution by hydroxide tablets.
28) The air purifier according to claim 12, further comprising a blower and a HEPA filter fitted in the inlet channel upstream to the reactor.
29) The air purifier according to claim 12 which is integrated with a domestic room purifier having a HEPA filter, wherein the inlet air channel is a branch from an inlet air channel of the domestic room purifier diverging downstream to the HEPA filter, and wherein the outlet channel joins an outlet channel of the domestic room purifier.
30) The air purifier according to claim 12, further comprising a sensor for measuring a concentration of CO.sub.2 at the room-air, and wherein a schedule and a period of operation of the device is based on CO.sub.2 measurements by said sensor.
31) A home air purifying system, comprising: a plurality of air-quality sensors, each sensor being positioned at another room of the home; a docking station which is configured to: host a mobile, air purifier; receive air quality measurements from all said plurality of sensors, and determine when a level of contamination at a room exceeds a predefined contamination threshold; and communicate with said mobile air purifier, and at least send to it an indication of a room in which a contamination above said predefined contamination threshold has been detected; and said mobile air purifier, which is configured to: communicate with said docking station, and at least receive from it an indication of the room in which the contamination above said predefined contamination threshold has been detected; upon receipt of said indication, navigate to the contaminated room, operate there to purify the room, and upon completion, return to the docking station.
32) The system according to claim 31, wherein said contamination comprises one or more chemical and biological contaminants.
33) The system according to claim 31, wherein said mobile air purifier comprises: an inlet air channel; one or more air sucking components configured to suck air from the room into said inlet channel, and to direct the air via said air channel into a perforated membrane mounted at a bio-hazards elimination reactor; and an outlet air channel configured to receive treated air from the reactor, and to return the treated air into the room; wherein the bio-hazards elimination reactor comprising: a reservoir configured to contain a purifying aqueous alkali hydroxide/H.sub.2O.sub.2 solution; wherein during the purifier operation said perforated membrane is positioned below a surface level of the solution such that air passing through the perforated membrane is converted into bubbles that travel through the solution and towards said outlet channel; and wherein the air purifier further comprising a removable storage unit positioned above the reactor, said removable storage unit is configured to contain and supply alkali hydroxide, hydrogen peroxide, and water to said reactor.
34) A method of improving indoor air quality, comprising: providing airflow through CO.sub.2 adsorption scrubber over a first period of time to capture CO.sub.2 by an adsorbent in the scrubber while reintroducing CO.sub.2-depleted air from the scrubber into a room; desorbing CO.sub.2 from the adsorbent during a second period of time while guiding air laden with the desorbed CO.sub.2 from the scrubber into a gas/liquid contactor charged with aqueous alkali hydroxide/H.sub.2O.sub.2 solution, passing the CO.sub.2-laden air through a perforated membrane installed in the gas/liquid contactor below the surface level of the aqueous alkali hydroxide/H.sub.2O.sub.2 solution, such that bubbles produced travel through said solution, and getting treated air with reduced CO.sub.2 level from said gas/liquid contactor.
35) An air purifier comprising: a device used to move air for supplying air flow through the air purifier; CO.sub.2 adsorption scrubber; a gas/liquid contactor located downstream of the scrubber; an outlet pipe to release air from the air purifier to the room; a first air flow line connecting said device to the outlet pipe, configured to direct incoming air stream to the adsorption scrubber, and outgoing air stream from the scrubber to said outlet pipe; a second air flow line connecting said device to the outlet pipe, configured to direct incoming air stream to the gas/liquid contactor, and outgoing air stream from the gas/liquid contactor to the outlet pipe; and a third air flow line connecting said device to the outlet pipe, configured to direct incoming air stream to the adsorption scrubber, and outgoing air stream from the scrubber to the gas/liquid contactor; an array of valves to guide the moving air through said first, second or third air flow lines; optionally a heater positioned downstream to the adsorption scrubber.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0061] In the drawings:
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0083]
[0084]
[0085]
[0086] In the structure presented in
[0087]
[0088] In one embodiment of the invention, controller 435 may periodically drain the entire purifying solution 438 into a waste container 454 and renew the solution by fresh content from cartridge A, Cartridge B, and water. In some cases, one or more of the cartridges contains aqueous MOH and/or aqueous H.sub.2O.sub.2. Therefore a separate cartridge for water may not be necessary. The inventors have found that the structure presented in
[0089] Also shown in
[0094]
[0095] The airborne bio-hazards purifier of the invention was tested. The purifier of the invention significantly reduces the level of bio-hazards (such as viruses and bacteria) in the air and reduces other toxic gases, such as CO.sub.2, CO, formaldehyde, etc.
[0096]
[0097]
[0098] Periodically, or based on any other definition, the docking station 712 is activated to drain the existing liquid from reservoir 738 of the mobile air purifier into sewage tank 748, and refill reservoir 738 with new liquids (or solids, as is applicable) from tanks 742, 744, and 746 (in predetermined proportions). The docking station and the mobile air purifier include additional components, such as pumps, valves, etc., to perform these tasks. The mobile air purifier also includes a blower for circulating air into the reservoir (in the form of bubbles, as described) and release it into the room.
[0099] The components that are required for the navigation may be divided between the mobile purifier and the docking station in various possible configurations. In one embodiment, the mobile purifier 710 maintains a full navigation capability (i.e., map of the house, etc.). The docking station can indicate the targeted room, and based on this indication, the mobile purifier navigates autonomously to the targeted room. In another configuration, the navigation capabilities are maintained within the docking station 712, while it sends real-time direction commands, such as right, left, forward, backward, move, stop, etc., to the mobile purifier.
[0100] The system may also include a remote control (for example, user smartphone 720). The remote control may define various parameters of the system.
[0101] As noted, the system preferably utilizes the Wi-Fi router of the house for communication between all its components. Other types of wireless networks may be used. Moreover, a central computer, which may be separate from the docking station, may be utilized to receive sensors' data and send commands to the mobile device. In such a case, the docking station serves only as a recharging station for the mobile air purifier.
[0102]
[0103]
[0104]
[0105]
[0106]
[0107]
[0108] Reference is now made particularly to
[0109] For example, the weight of each tablet may be about 5 to 100 g, e.g., from 15 to 30 g, and 2 to 100 tablets may be included within cartridge 826. The water container may contain 1 to 10, e.g., 2 to 6 liters, and the hydrogen peroxide container may include between 250 ml and 10 liter. Initially, the user removes the storage unit using handle 863 and fills it with the solution ingredients. Upon filling the water container with tap water, and filling cartridges A 826 and B 828 with tablets and liquid, respectively, and remounting the storage unit at the purifier, the device is ready for operation. The water is poured down to the reactor via pipe 853, and one tablet (or more, if necessary) is dropped down to the solution via opening (and respective pipe) 859. A dose of the hydrogen peroxide is conveyed periodically into proximity of the perforated membrane utilizing pump 839, pipe 855 (one or more pipes may be used), and respective perforations (not shown) on tube 855a (
[0110] During the process, air from the sump penetrates solution 838 via the membrane's 836 perforations, creating bubbles that interact with the solution as described above. The bubbles leave the solution as a purified air. The purified air passes through demister 846, which removes from the purified air residues of aerosol and droplets of the reactive liquid that the airflow may carry. The outlet of the demister includes a funnel (not shown), which is connected to a pipe (not shown) leading to the carbon filter 849.
[0111] After some period of operation, the effectiveness of solution 838 reduces to a degree requiring entire replacement by fresh water and ingredients from cartridges A and B, respectively. When such a necessity arose, pump 857 pumps and conveys the entire liquid content of compartment 820 (
[0112] The inventions' process is optimized when as small as possible and as many as possible bubbles are simultaneously created. This configuration maximizes the overall interaction surface between the bubbles and solution 838. However, it has been found that a membrane with too close perforations results in vast merges of proximate bubbles, as illustrated in the prior art membrane 896 of
[0113]
[0114] In some cases, the height of the lower cylindrical section of the perforation is reduced (compared to the upper conical section's height). In some other cases, the lower cylindrical section of the perforation may be eliminated, resulting in a truncated cone cross-section.
[0115] Purifier 800 may be stationary, mobile (in similarity to embodiment 700), or manually carried from one room to another.
[0116]
[0117] Another aspect of the invention involves modifying the indoor air treatment program offered by the MOH/H.sub.2O.sub.2 reactor described above, by incorporating a CO.sub.2 adsorption scrubber upstream of the MOH/H.sub.2O.sub.2 reactor. A battery consisting of CO.sub.2 adsorption scrubber and MOH/H.sub.2O.sub.2 reactor offers greater versatility in coping with changes in CO.sub.2 levels in the room, and better management of alkali hydroxide and hydrogen peroxide feed supply to the reactor, because the battery can switch between different modes of operation, depending chiefly on factors such as CO.sub.2 level in the room and presence of occupants in the room. The CO.sub.2 adsorption scrubber and MOH/H.sub.2O.sub.2 reactor may be designed to operate with airflows supplied at different volumetric rates (high and low, respectively).
[0118] Reduction of CO.sub.2 levels in indoor air can be achieved in different ways using a battery consisting of CO.sub.2 adsorption scrubber and MOH/H.sub.2O.sub.2 reactor:
[0119] 1) by the action of adsorption scrubber alone: indoor air is passed through the scrubber; CO.sub.2 is captured and held for some time in the scrubber. During that period of time, air with improved quality is supplied to the room from the scrubber. The scrubber is discharged by releasing CO.sub.2 to the room, e.g., overnight.
[0120] 2) by the action of MOH/H.sub.2O.sub.2 reactor alone: indoor air is guided directly to the MOH/H.sub.2O.sub.2 reactor, bypassing the adsorption scrubber; CO.sub.2 is transformed into harmless carbonate/bicarbonate salts; air with improved quality is supplied to the room from the reactor.
[0121] 3) by a combined mode of operation: indoor air flows through the scrubber over a period of time during which the MOH/H.sub.2O.sub.2 reactor is at rest. CO.sub.2 is captured and held in the scrubber but after a while the MOH/H.sub.2O.sub.2 reactor enters into service such that CO.sub.2 discharged from the scrubber is directed to, and mineralized in, the MOH/H.sub.2O.sub.2 reactor.
[0122] Accordingly, one aspect of the invention relates to the combined mode of operation outlined above, i.e., by capturing and holding CO.sub.2 is an adsorption scrubber, and after a while, discharging the CO.sub.2 from the scrubber and mineralizing the CO.sub.2 in the MOH/H.sub.2O.sub.2 solution, i.e., to a method of improving indoor air quality, comprising:
[0123] providing airflow through CO.sub.2 adsorption scrubber over a first period of time to capture CO.sub.2 by an adsorbent in the scrubber while reintroducing CO.sub.2-depleted air from the scrubber into a room; desorbing CO.sub.2 from the adsorbent during a second period of time (for example, by heating the adsorption scrubber to reach desorption temperature) while guiding air laden with the desorbed CO.sub.2 from the scrubber into a gas/liquid contactor charged with aqueous alkali hydroxide/H.sub.2O.sub.2 solution, passing the CO.sub.2-laden air through a perforated membrane installed in the gas/liquid contactor below the surface level of the aqueous alkali hydroxide/H.sub.2O.sub.2 solution, such that bubbles produced travel through said solution, and getting treated air with reduced CO.sub.2 level from said gas/liquid contactor.
[0124] Another aspect of the invention is an air purifier based on a battery consisting of CO.sub.2 adsorption scrubber and MOH/H.sub.2O.sub.2 reactor, which can improve indoor air quality by the three options set out above. In its most general form, the air purifier comprises:
[0125] a device used to move air, e.g., a blower or a fan, for supplying continuous air flow through the air purifier;
[0126] CO.sub.2 adsorption scrubber;
[0127] a gas/liquid contactor located downstream of the scrubber;
[0128] an outlet pipe to release air from the air purifier to the room; a first airflow line connecting the blower or the fan, to the outlet pipe, configured to direct incoming air stream to the adsorption scrubber, and outgoing air stream from the scrubber to the outlet pipe;
[0129] a second air flow line connecting the blower or the fan to the outlet pipe, configured to direct incoming air stream to the gas/liquid contactor, and outgoing air stream from the gas/liquid contactor to the outlet pipe; and
[0130] a third air flow line connecting the blower or the fan to the outlet pipe, configured to direct incoming air stream to the adsorption scrubber, and outgoing air stream from the scrubber to the gas/liquid contactor;
[0131] an array of valves to guide the moving air through said first, second or third air flow lines;
[0132] and optionally a heater positioned downstream to the adsorption scrubber.
[0133]
[0134] A blower (1) provides airflow through the air purifier, capable of supplying volumetric flow rate of 100-2000 litre/min, adjusted to fit the selected mode of operation, as explained below. The airflow moves via, e.g., 15-50 mm diameter conduits installed in the air purifier, and is directed to the air outlet (9) via a path regulated by the states of valves (4), (5), (6) and (7), i.e., after the airflow was passed through the adsorption scrubber (2) or the gas/liquid contactor (3).
[0135] CO.sub.2 adsorption scrubbers (2) suitable for use in the invention exist in the marketplace, utilizing physisorption or chemisorption-based sorbents. A simple design is of a fixed-bed scrubber, usually a vertical cylindrical fixed-bed scrubber, as shown in
[0136] The air purifier may include a heating unit (8) positioned downstream to CO.sub.2 adsorption scrubber (2), in the form of a convection heater in which an electric heating coil is installed, operating at 100-3000 watt. To goal served by heating unit (8) is to enable CO.sub.2 adsorption scrubber (2) to switch from adsorption to desorption, i.e., to regenerate the sorbent material after it reached saturation or nearly saturation, by passing heated air through the scrubber. Rise in temperature causes CO.sub.2 molecules to detach from the sorbent surface. In the embodiment of the invention shown in
[0137] HEPA filter (not shown) is placed downstream to blower (1) or upstream to air outlet (9). Whereas blower (1), CO.sub.2 adsorption scrubber (2) and heating element (8) are fairly conventional, the gas/liquid contactor (3) has unique configuration which was described in detail above.
[0138]
[0139] Perforated membrane is mounted at the lower part of the reactor, below the surface level of the MOH/H.sub.2O.sub.2 aqueous solution. One useful design of the perforated membrane is shown in
[0140]
[0141] The unique geometrical motifs of membrane (836) and their useful effect are perhaps better illustrated in
[0142] Turning back to
[0143] In the variant of
[0144]
[0145] The upper portion of the gas/liquid contactor (870) consists of a storage unit which includes three concentric containers, as follows: Cartridge A container (826) for the alkali hydroxide (NaOH, KOH or both, (in a tablet form), water container (847), and H.sub.2O.sub.2 container (cartridge B) (828). Cartridge A is divided into a plurality of column cylinders (826a), each containing a plurality of tablets. In an embodiment of the invention, the plurality of column cylinders (826a) are arranged in a revolving drum (845). To add MOH tablet to the reaction zone, a motor (not shown) rotates the drum 845 to angularly position a tablets' column (826a) above opening accessing the reaction zone, enabling one or more tablet(s) to fall into the reaction zone (850). Hydrogen peroxide is supplied using a pump, via pipe (828p), below the level of the solution (838). Demister (846) is also included.
[0146] For example, the weight of each tablet may be about 5 to 100 g, e.g., from 15 to 30 g, and 2 to 100 tablets may be included within cartridge (826a). The water container may contain 1 to 10, e.g., 2 to 6 liters, and the hydrogen peroxide container may include between 250 ml and 10 liter.
[0147] Turning back to
[0148] According to the first mode of operation, blower (1) supplies airflow through CO.sub.2 adsorption scrubber (2) and moves depleted-CO.sub.2 airflow which exists the scrubber via air outlet (9) to be reintroduced into the room, by keeping two-way valves (7) and (5) open and two-way valves (6) and (4) closed. The air purifier switches to such mode of operation in response to detecting increased CO.sub.2 levels in the room, or is programmed to operate likewise during time periods at which relatively high CO.sub.2 levels are anticipated, e.g., when a large number of attendees is expected, such as when a meeting takes place in the room. Because only the CO.sub.2 adsorption scrubber is at service while the gas/liquid is disconnected, the air purifier can operate with the blower (1) supplying airflow at a fairly high volumetric flow rate, over short time periods, i.e., a couple of hours or so. When the sorbent material becomes saturated, or after the people (e.g., workers, meeting participants) have left the room, the scrubber regeneration phase may start, e.g., heating unit (8) is turned on so as to feed the scrubber with hot air and release air laden with CO.sub.2 through air outlet (9). It is noted that this mode of operation largely deals with peak CO.sub.2 levels in the room, to produce and constantly reintroduce CO.sub.2-deplated airflow to the room when it occupied by people, without chemically eliminating the CO.sub.2 molecules.
[0149] According to the second mode of operation, blower (1) supplies airflow through gas/liquid contactor (3), i.e., bypassing scrubber (2) and moves depleted-CO.sub.2 airflow which exists the gas/liquid contactor (3) via air outlet (9) to be reintroduced into the room, by keeping two-way valves (6) and (4) open and two-way valves (7) and (5) closed. Volumetric flow rates received by the gas/liquid contactor are generally lower than those received by the scrubber, just holding CO.sub.2 temporarily in the scrubber (2).
[0150] According to the third mode of operation, blower (1) supplies airflow through CO.sub.2 adsorption scrubber (2) and moves depleted-CO.sub.2 airflow which exists the scrubber via air outlet (9) to be reintroduced into the room over a period of time t.sub.1 during which the MOH/H.sub.2O.sub.2 reactor (3) is at rest, by opening two-way valves (7) and (5) and closing two-way valves (6) and (4). During t.sub.1, CO.sub.2 is captured and held in the scrubber but after a while the MOH/H.sub.2O.sub.2 reactor enters into service. That is, CO.sub.2 is discharged from the scrubber (2) and is directed to, and mineralized in, the MOH/H.sub.2O.sub.2 reactor (3), by keeping two-way valve (7) open, turning on the heater to supply hot air thereby promoting the desorption process of the CO.sub.2 molecules from the sorbent in scrubber (2), to produce CO.sub.2-laden airflow. Two-way valve (5) and (6) are closed whereas two-way valve (4) is open, such that the CO.sub.2-laden airflow is passed through gas/liquid contactor (3).
[0151] CO.sub.2-laden air delivered to gas/liquid contactor (3) over a period of time t.sub.2, and is forced to flow across the membrane (236) to create bubbles which are caused to travel through the alkali hydroxide solution (e.g., NaOH or KOH, or their mixture), to which H.sub.2O.sub.2 stream is periodically or continuously added (for example, by injection beneath the level of the alkali hydroxide solution, in close proximity to the perforated membrane, i.e., in the vicinity of the perforations). Concentration of the alkali hydroxide solution varies from 5% to 481-50% by weight, e.g., from 10 to 48%-50% by weight. The concentration of the hydrogen peroxide solution added to the alkali hydroxide solution is from 3%, 4%, or 5% up to 35% by weight, e.g., from 10 to 30% by weight. Acceptable addition rate of the H.sub.2O.sub.2 stream may vary from 0.01 ml/min to 10 ml/min, e.g. up to 2, 3 or 4 ml/min. The volumetric ratio between the solutions in the range of 2:1 to 10:1 in favor of the alkali hydroxide solution. In the combined mode of operation (CO.sub.2 capture in scrubber (2), CO.sub.2 mineralization in reactor (3)), t.sub.1<t.sub.2, that is, the scrubber captures CO.sub.2 during relatively short time periods at CO.sub.2 peak hours, whereas reactor (3) runs the chemical elimination of CO.sub.2 with low volumetric flow rate over an extended time period.
EXAMPLES
Example 1
Removal of Formaldehyde Vapours from Air by Absorption to Aqueous Solution of Sodium Hydroxide and Hydrogen Peroxide
[0152] The goal of the study was to test the ability of the aqueous NaOH/H.sub.2O.sub.2 reagent to remove formaldehyde vapors from air that is passed/bubbled through the reagent and decompose the formaldehyde, challenging characteristic formaldehyde indoor loading and maintaining adequate formaldehyde conversion rates over a couple of hours.
[0153] The experimental set-up is shown in
[0154] The formaldehyde solution was vaporized using hot plate (2) with an average temperature of 35° C. and the vapors were led to reactor (4). The peristaltic pump (3) used was operated at 1 m.sup.3/min flow rate. The formaldehyde concentration in the incoming stream was adjusted to 0.2-0.3 mg/m.sup.3 in air, representing typical contamination level in residential areas, based on WHO guidelines for Indoor Air Quality. A pair of formaldehyde detectors (5-formaldemeter htv-m, manufactured by PPM technology Ltd., UK) connected to the incoming (contaminated) and outgoing (purified) streams were used to measure the concentration of formaldehyde, respectively.
[0155] Results of characteristic experiments are shown graphically in
Example 2
Treatment of Low Concentration CO.SUB.2.-Bearing Air by Absorption to Aqueous Solution of Sodium Hydroxide and Hydrogen Peroxide
[0156] The goal of the study was to test the ability of the aqueous NaOH/H.sub.2O.sub.2 reagent to remove CO.sub.2 from air that is passed/bubbled through the reagent, when the air is loaded with low CO.sub.2 concentrations, challenging characteristic CO.sub.2 indoor loading and maintaining adequate CO.sub.2 conversion rates over a couple of hours.
[0157] The experimental set-up is shown in
[0158] CO.sub.2 levels in the incoming and outgoing streams were recorded continuously over forty minutes. The results are presented graphically in
[0159] Reaction of CO.sub.2 with alkali hydroxide alone would merely result in formation of the corresponding carbonate, as shown by the following reaction equation:
CO.sub.2+2MOH.fwdarw.M.sub.2CO.sub.3+H.sub.2O
[0160] In contrast, reaction of carbon dioxide with the superoxide leads to formation of oxygen:
2MO.sub.2+CO.sub.2.fwdarw.M.sub.2CO.sub.3+1.5O.sub.2
[0161] Hence, the involvement of the superoxide radical in decomposing of CO.sub.2 is demonstrated by evolution of O.sub.2. That is, enrichment of the outgoing air stream with oxygen. Oxygen levels in the incoming and outgoing streams recorded over forty minutes indeed indicate oxygen evolution and creation of oxygen-rich outgoing air stream, as shown by the O.sub.2 concentration versus time plot of
Example 3
Reduction of Microbial Load in Air with the Aid of Aqueous Solution of Sodium Hydroxide and Hydrogen Peroxide
[0162] The goal of the study was to investigate the biocidal action of NaOH/H.sub.2O.sub.2 reagent on contaminated air, that is, to achieve reduction of microbial load of indoor air, e.g., by removing bacteria such as Micrococcus luteus, Bacillus and Clostridium. The initial load was 1*10.sup.8 CFU/ml for each of the bacteria species tested (which is approximately equal to 400 CFU/plate contaminated air).
[0163] The Experimental set-up is shown in
[0164] Biocide contact time was fifteen minutes. A sealed container accommodating six petri dishes was used to receive the treated air existing reactor (4) after the fifteen minutes elapsed. It was found that 15 minutes of exposure to the superoxide radical (active solution) achieved reduction of bacteria concentration to 2 CFU/plate, indicating conversion rate of 99.51.
Example 4
Reduction of Microbial Load in Air with the Aid of Aqueous Solution of Sodium Hydroxide and Hydrogen Peroxide
[0165] Experimental Set-Up
[0166] The experimental set-up is shown in
[0167] (A) a mixing unit, where an air stream is loaded with biological contamination.
[0168] (B) a treatment unit, i.e., a gas-liquid contactor, where the biologically contaminated air stream is treated with the aqueous MOH/H.sub.2O.sub.2 solution.
[0169] (C) a filtration and sampling unit, where condensable samples are collected; the so-formed solutions are then analysed (to count the microorganisms that survived the treatment).
[0170] The Mixing Unit (A)
[0171] Air stream from an air compressor (1) is passed through an air filter (2) before it enters a mixing chamber (4) at a pressure of 5 bars (flow rate of about 100 L/min). The air feed line is equipped with a regulator and a flowmeter (3) to adjust the air flow rate. Syringe pump (7; NE-300 Just-Infusion™, by New Er Pump Systems Inc.) delivers a microbial suspension to a bioaerosol generator (6; Blaustein atomizer (BLAM), a multi-jet model by CH technologies), where it becomes small and light enough to be carried on air. The BLAM atomizer is installed inside mixing chamber (4), discharging the bioaerosol at the lower portion (5) of mixing chamber (4), at a flow rate of 6 L/min, where the bioaerosol is loaded onto the compressed air fed to chamber (4), creating biologically contaminated air stream. Chamber (4) is also provided with a jet nozzle port (not shown) to introduce a disinfectant (6-10% hydrogen peroxide solution) and a secondary air stream, creating a disinfectant aerosol to clean the interior of chamber (4) between the tests. An outgoing, biologically contaminated air stream flows from chamber (4) to the treatment zone at about 106 L/min.
[0172] The Treatment Zone (B)
[0173] A reactor, i.e., a gas-liquid contactor, where the biologically contaminated air is mixed with the aqueous reagents MOH/H.sub.2O.sub.2, is indicated by numeral (8). Reactor (8) is tubular in shape (inner diameter: 9 cm; height: 40 cm). 5 mm thick stainless steel membrane (9) is mounted horizontally inside the reactor, about 2.5 cm from the bottom the reactor. The pore size of the membrane was 147 μm; centre to centre distance between adjacent pores is ˜50 μm. Sodium hydroxide (30% by weight solution) and hydrogen peroxide (10%-30% by weight solutions) are held at tanks (11) and (12), and are supplied to reactor (8) using peristaltic pumps operated under controllers 15 and 16. The NaOH and H.sub.2O.sub.2 aqueous streams enter the reactor (8) through openings located at the lateral surface of the reactor, below the level of the membrane (9). A third peristaltic pump C (not shown) is installed to discharge the exhausted aqueous reagent from the bottom of reactor (8) to a waste tank (not shown). Numeral (10) indicates the surface level of the aqueous reagent added to the gas-liquid contactor (8). An outgoing disinfected air stream (13) flows to the filtration and sampling unit.
[0174] The Filtration and Sampling Unit (c)
[0175] The filtration and sampling unit (3) consists of a dry filter air sampler (14); ACD-200 Bobcat). The air effluent of reactor (13) is passed through the Bobcat sampler (controlled by (17)) which generates liquid samples for analysis. That is, the collected fluid is withdrawn from the Bobcat sampler and samples (5-7 ml) are incubated to detect and count the microorganism. The experimental set-up is mounted inside a hood, such that air sampler (14) is fed with the treated air stream (13) delivered from reactor (8) with minimal ambient air interference.
[0176] Experimental Protocol
[0177] The strain of bacteria chosen for the tests was Kocuria rhizophila (ATCC 9341). It is readily visible when grown on agar plate, owing to its spherical morphology and intense yellow color. TSB was used as a culture broth to grow the bacteria (overnight, at 30-35° C.).
[0178] Each session consisted of the following experiments:
[0179] One negative control experiment, in which purified water is injected from the syringe pump (7) to the aerosol generator (6), creating a sterile aerosol that is discharged to chamber (4), where it is mixed with incoming sterile air stream. The outgoing air/aerosol stream flows to reactor (8). Reactor (8) operates under dry conditions, i.e., the air stream is not contacted with a liquid whatsoever. The aerosol moves to the Bobcat sampler (14), condensed, collected and tested for the presence of the bacteria (no bacterial growth was to be detected in a successful run).
[0180] Two or more test experiment, in which a microbial suspension is injected from the syringe pump (7) to the aerosol generator (6), creating a bioaerosol that is discharged to chamber (4), where it was mixed with incoming sterile air stream. The air/bioaerosol stream from chamber (4) flows to reactor (8); it enters reactor (8) from the bottom, flows in an upward direction across the aqueous NaOH/H.sub.2O.sub.2 solution. The outgoing, disinfected air/aerosol stream flows from the top of reactor (8) to the Bobcat sampler (14), samples are condensed, collected and tested for the presence of the bacteria. The combinations of NaOH/H.sub.2O.sub.2 aqueous solutions added to reactor (8) are tabulated below:
TABLE-US-00001 TABLE 1 Treatment A1 A2 NaOH 30% solution 3.0 liter 3.0 liter H.sub.2O.sub.2 10% solution 0.3 liter H.sub.2O.sub.2 30% solution 0.3 liter
[0181] One positive control experiment, which only differs from the test experiment in that reactor (8) was filled with purified water in place of the active NaOH/H.sub.2O.sub.2 solution. The positive control experiment showed that the system does not block the passage of microorganism and functioned as the positive baseline to which each test was com-pared to, on each session, to evaluate the efficacy of the treatment. Positive control runs were performed once per session, usually after the test experiments.
[0182] System disinfection was performed at the beginning of each session and after each test involving the passage of microorganisms into the system (see the 6-10 H2O2 disinfectant arrangement mentioned above); i.e., reactor (8) was drained to discharge the exhausted aqueous reagent, and the system was cleaned and disinfected. Samples collected were diluted (e.g., 10.sup.−5 dilution), disposed on agar plates to enable CFU counting.
[0183] Results
[0184] The concentration and total number of CU injected to create the contaminated biological air stream and removal rates measured (expressed by log reduction units, calculated based on total CFU injected and relative to the positive control base) are tabulated in Table 2.
TABLE-US-00002 TABLE 2 Treatment A1 A2 CFU injected 8.1 × 10.sup.6 CFU/ml 5.3 × 10.sup.6 CFU/ml Total: 4.05 × 10.sup.8 CFU Total: 2.65 × 10.sup.8 CFU Log reduction* 3.3-3.9 5.6-8.4 Log reduction** 1.6-2.2 3.6-6.4 *calculated based on total CFU injected. **calculated relative to positive control
[0185] It is seen that the combined action of alkali hydroxide and hydrogen peroxide achieved high removal rates of the bacteria Kocuria rhizophila from air (>99.99% elimination).
Example 5
Inactivation of Human Coronavirus OC43(hCoV-OC43) by the Action of Sodium Hydroxide and Hydrogen Peroxide
[0186] The goal of the study was to evaluate the effect of direct contact of NaOH/H.sub.2O.sub.2 aqueous solution on hCoV-OC43, over different exposure times.
[0187] Pre-Test Preparations
[0188] Biological samples: A549 cells (Colon; ATCC, Cat. #CCL-185) were grown in 96-well plates (96-well plate, Greiner Bio One) in F-12K growth medium (ATCC, Cat. #30-2004) supplemented with 2 mM L-Alanyl-L-Glutamine solution (200 mM; Biological Industries, Cat. #03-022-1B), 1% Penicillin-Streptomycin solution (Biological Industries, Cat. #03-031-1B) and 10% Fetal Bovine Serum (FBS; Biological Industries, Cat. #04-127-1A), at 37° C. and 5% CO.sub.2.
[0189] Chemical samples: 300 μl of H.sub.2O.sub.2 10% solution were added to 9 ml of NaOH 30% solution, to form 9.3 ml samples of the active reagent.
[0190] Experimental Protocol
[0191] Test A: Negative Control—Cytotoxic Effect of NaOH/H.sub.2O.sub.2 Solution
[0192] Two experiments were conducted to determine the cytotoxicity of the NaOH/H.sub.2O.sub.2 solution.
[0193] In experiment 1-310 μl sterile growth medium were added to 9.3 ml of the NaOH/H.sub.2O.sub.2 solution and incubated for 60 seconds, followed by preparation of 10-fold serial dilutions (1:10, 1:100, 1:1000, 1:10000, 1:100000 and 1:1000000), and adding 150 μl/well from each dilution to the cells in 4 replicate wells.
[0194] In experiment 2-500 μl sterile growth medium were added to 500 μl of the NaOH/H.sub.2O.sub.2 solution, and incubated for 10 seconds, followed by preparation of 10-fold serial dilutions (1:10, 1:100, 1:1000, 1:10000, 1:100000 and 1:1000000) and adding 150 μl/well from each dilution to the cells in 4 replicate wells.
[0195] Test B—Antiviral Effect of NaOH/H.sub.2O.sub.2 Solution
[0196] Two experiments were conducted to assess the antiviral effect of the of the NaOH/H.sub.2O.sub.2 solution.
[0197] In experiment 1—310 μl of stock hCoV-OC43 were added to 9.3 ml of the NaOH/H.sub.2O.sub.2 solution, and incubated for 13, 30 and 60 seconds (total 3 test samples), followed by preparation of 10-fold serial dilutions (1:10, 1:100, 1:1000, 1:10000, 1:100000 and 1:1000000) and adding 150 μl/well from all dilutions produced at each incubation duration, to the cells in 4 replicate wells.
[0198] In experiment 2—500 μl of stock hCoV-OC43 were added to 500 μl of the NaOH/H.sub.2O.sub.2 solution and incubated for 2, 5 and 10 seconds (total 3 test samples), followed by preparation of 10-fold serial dilutions (1:1000, 1:10000, 1:100000 and 1:1000000) and adding 150 μl/well from all dilutions produced at each incubation duration, to the cells in 4 replicate wells.
[0199] Viral Standard Curve Preparation for Stock Titration:
[0200] Untreated hCoV-OC43 stock was diluted in 10-fold serial dilutions in sterile growth medium supplemented with 2% FBS, and 150 μl/well were applied from each dilution to the cells in 4 replicate wells.
[0201] Four (4) additional wells were used as calibration curve negative control (cNC), in which sterile medium containing no hCoV-OC43 was applied onto the cells.
[0202] The A549 96-well plate was incubated for 6 days at 35° C. and 5% CO2, and cells were daily monitored for cytopathic and/or cytotoxic effects under the microscope.
[0203] Results
[0204] Viral Standard Curve
[0205] Viable and uninfected/contaminated cells were observed in all cNC wells in both experiment 1 and 2.
[0206] In experiment 1 standard curve titration calculated using the Reed and Much titration formula was: 2.11.Math.10.sup.6 TCID.sub.50/ml.
[0207] In experiment 2 standard curve titration calculated using the Reed and Much titration formula was: 3.09.Math.10.sup.7 TCID.sub.50/ml.
[0208] The results indicate that the virus stock used in each experiment stands in the calibration range of our viral stocks and is reliable for experimentation.
[0209] Test A: Negative Control—Cytotoxic Effect of NaOH/H.sub.2O.sub.2 Solution
[0210] Cytotoxicity leading to cell death within hours was observed in both experiments for all replicates of dilutions 1:10 and 1:100. At dilution 1:1,000 and above, no cell death, and no difference in cell appearance were observed, compared to untreated cells incubated in growth medium and no chemical treatment.
[0211] The antiviral experiment was conducted accordingly, referring to the 1:1,000 viral dilution as a baseline for CPE monitoring and TCID.sub.50 calculations.
[0212] Test B—Antiviral Effect of NaOH/H.sub.2O.sub.2 Solution
[0213] No cytotoxic effect was observed for dilutions of 1:1,000 and above of the NaOH/H.sub.2O.sub.2 solution, no viral infection was observed for all test samples in all wells infected by treated virus containing these dilutions. That is, hCoV-OC43 infectivity by at least ≥99.9%, already at 2 seconds of contact with the virus. These percentages can be interpreted based on Table 5, for the calculated −3.7 viral log reduction obtained as the result for the 3 Test samples (Table 4).
[0214] Since no TCID.sub.50 could be calculated in any of the 3 test sample wells, calculation of the viral log reduction was based on the delta between the calculated TCID.sub.50 units that were inoculated (following incubation with the chemical mixture) into each well of the 1:1,000 dilutions, and the end-point viral titer obtained (0). The TCID.sub.50 inoculated into the wells was calculated based on the standard curve samples.
TABLE-US-00003 TABLE 3 antiviral activity experiment 1 Initial viral Observed viral Viral log % Virus Samp1e TCID.sub.50/well TCID.sub.50 day 5 reduction reduction TEST 13 s 1.02E+01 0 1 ≥90 TEST 30 s 0 1 ≥90 TEST 60 s 0 1 ≥90
TABLE-US-00004 TABLE 4 Chemical mixture antiviral activity experiment 1 Initial viral Observed viral Viral log % Virus Sample TCID.sub.50/well TCID.sub.50 day 7 reduction reduction TEST 2 s 4.64E+03 0 3.7 ≥99.9 TEST 5 s 0 3.7 ≥99.9 TEST 10 s 0 3.7 ≥99.9
[0215] Legend for Table 3 and 4:
[0216] Initial viral TCID.sub.50/well: the total amount of hCoV-OC43 inoculated into the 96-well plate and onto the cells, at dilution 1:1,000 of the chemical mixture following incubation for 13, 30 and 60 seconds (Table 3), and 2, 5 and 10 seconds (Table 4) of the virus in the aqueous NaOH/H.sub.2O.sub.2 solution. This value was calculated based on the titration of the viral standard curve wells, using the Reed and Much titration formula, and normalization to the total volume inoculated into the wells following the dilution (150 μl). The initial viral TCID.sub.50/well was only calculated for the 1:1,000 sample dilutions, as up to 1:100 there was massive cell death not allowing for CPE (cytopathic effect) observation.
[0217] Observed viral TCID.sub.50: the TCID.sub.50 obtained for each sample at the experiment end-point (5 and 7 days post viral inoculations). As no CPE and infection were visible, all samples were assigned 0 TCID.sub.50.
[0218] Viral log reduction: was calculated per the 1:1,000 sample dilutions as log.sub.10 from the initial viral TCID.sub.50 per well).
TABLE-US-00005 TABLE 5 Interpretation of results Log reduction Percent (%) reduction ≥1 ≥90 ≥2 ≥99 ≥3 ≥99.9
CONCLUSION
[0219] In this study, a chemical mixture of 9 ml NaOH solution and 300 μl H.sub.2O.sub.2 solution was tested for its ability to hamper the infectivity of hCoV-OC43 by direct contact of the solution and virus. Results of the three tests performed, for three different contact durations, indicate that the tested NaOH/H.sub.2O.sub.2 solution abolished virus infectivity as soon as 2 seconds following the direct exposure. Since there was cytotoxic effect of the NaOH/H.sub.2O.sub.2 solution to the cells at up to 1:100 dilution, in these wells CPE observations were not possible. As to 1:1,000 dilution and above, we can conclude that the NaOH/H.sub.2O.sub.2 solution indeed reduced ≥99.9% the viral load capable of infecting the cells, compared to the load first introduced into the wells of this dilution following incubation in the mixture. This reduction can be assessed as at least −3.7 log reduction in hCoV-OC43 virus infectivity.
Example 6
Treatment of Low Concentration CO.SUB.2.-Bearing Air by Absorption to Aqueous Solution of Potassium Hydroxide and Hydrogen Peroxide
[0220] The goal of the study was to examine the performance of two types of perforated membranes which differ from one another in the geometry of their holes. In one membrane, the diameter of the holes does not vary across the membrane thickness, i.e., the air flows through passages which are cylindrically in shape, with constant diameter of 600 μm. The other membrane that was tested was perforated with holes with unique geometry, as the air flows through passages consisting of a cylindrical section joining an inverted frustoconical section: to move across the membrane, the air flows through the cylindrical section, with diameter of 300 μm, then through the frustoconical section, whose small base is contiguous with the cylindrical section (they are equal in diameter). The large base of the frustoconical section, with diameter of 900 μm, is the opening of the hole in the side of the membrane facing the bulk solution.
[0221] The experimental set-up was similar to the one described in Example 2, but was larger in scale. Also, this time potassium hydroxide solution 50% was used. 1.1 L of the KOH solution was charged to a tubular reactor with diameter of 26.5 cm. The membrane tested was installed 2.5 cm from the bottom of the tubular reactor. H.sub.2O.sub.2 solution (10%) was added at a flow rate of 10 ml/hour over the test period, by intermittently operating the pump delivering the H.sub.2O.sub.2 solution. CO.sub.2 feed and its mix with an air stream to create a combined stream of 1200 ppm-CO.sub.2 bearing air were carried out as described in Example 2; this stream was fed at a flow rate of 120 L/min to the reactor, where the KOH/H.sub.2O.sub.2 reagent was held.
[0222] CO.sub.2 levels in the incoming and outgoing streams were recorded periodically over one hour by the arrangement described in Example 2, and conversion rates were calculated. The results are shown in the form of a bar diagram in